Loading AI tools
Medical condition From Wikipedia, the free encyclopedia
Thalamic gliomas are very rare, deep-seated, generally high-grade glial neoplasms that form in the thalamus, representing 1–5% of all pediatric brain tumors.[1] Because of their difficult to reach position, they are a unique and difficult challenge for neuro-oncologists and neurosurgeons.
Thalamic glioma | |
---|---|
Specialty | Neuro-oncology, neurosurgery |
Causes | Unknown |
Prevention | Unknown |
Treatment | Watchful waiting, radiation therapy, chemotherapy, resection |
Prognosis | Two year survival rate 19.7% (adults), pediatric five year survival rate 15-25% (high grade astrocytoma) or 40% (low grade astroyctoma) |
Thalamic gliomas are most often discovered on magnetic resonance imaging following symptoms, with the most common presenting symptom being motor deficit.[2] While a definitive diagnosis of the neoplasm cannot be made without a biopsy of the tumor, biopsies have historically been avoided due to the extreme sensitivity of the region.
A notable variant of thalamic gliomas are bithalamic gliomas. Bithalamic gliomas cross the interthalamic adhesion and occupy space in both thalami. These have poorer outcomes than unilateral thalamic gliomas.[3]
Unless a thalamic glioma shows aggressive behavior, they are often treated with a "watch and wait" approach until signs of growth occur.[4] Thalamic gliomas can be treated with radiotherapy, chemotherapy, and/or resection.[5]
Thalamic gliomas are among the most difficult challenges a neurosurgeon faces today. Historically, thalamic gliomas were considered inoperable.[6] Advances in neurosurgical technology have opened up the thalamic area to resection, but conservative approaches remain popular.[7] Microsurgical approaches are well suited for thalamic gliomas.[8]
Thalamic gliomas have a poor prognosis. In adult patients, the overall two-year survival rate is 19.7%, with low grade tumors holding a two-year survival rate of 31.0% and high-grade tumors holding a two-year survival rate of 16.5%.[2] In pedtiatric patients, low-grade astrocytomas held a five-year survival rate of 40% while high-grade astrocyte tumors held a five-year survival rate that varies between 15% and 25%.[9] Strangely, pediatric thalamic oligodendrogliomas appear to have a far worse prognosis than thalamic astrocytomas, with a three-year survival rate of 14% in one series.[9]
Higher Karnovsky performance status and CSF diversion[10] are good prognostic markers in cases that match the criteria for glioblastoma.
While the H3K27m mutation that is the distinct marker of a diffuse midline glioma is generally a very poor prognostic factor, it is unusually associated with slightly higher rates of survival in adult thalalmic glioma patients.[11]
Thalamic gliomas are often but not exclusively diffuse midline gliomas; other varieties of glial tumor can develop in this region.[2]
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.